|
|
|
|
|
|
|
21.10.26 - 18:33
|
William Blair Expands Biotech Research as Veteran Analyst Alethia Young Initiates Coverage (Business Wire)
|
|
|
CHICAGO--(BUSINESS WIRE)--William Blair today announced that Alethia Young has initiated coverage of 13 biotechnology companies, marking the next step in the firm's continued expansion of its biotech offering.
Young joined William Blair in May 2026 as part of a broader investment in the firm's equities platform. With 25 years of experience across biotechnology and healthcare, she brings a perspective shaped by roles on both Wall Street and within the industry, most recently as chief financial officer of Bicycle Therapeutics.
Young's initial coverage spans 13 biotechnology companies: Ascentage Pharma Group (AAPG), Cytokinetics (CYTK), Edgewise Therapeutics (EWTX), Faeth Therapeutics (FTH), IDEAYA Biosciences (IDYA), Immunome (IMNM), Kardigan (KARD), Palvella Therapeutics (PVLA), Arcus Biosciences (RCUS), Revolution Medicines (RVMD), Rhythm Pharmaceuticals (RYTM), Tango Therapeutics (TNGX), and Wave Life Sciences (WVE).
Her inaugural research focuses on several themes shaping opportunities across biotech...
|
|
|
|
|
20.10.26 - 14:33
|
Wave Life Sciences Third Quarter 2026 Financial Results Scheduled for October 27, 2026 (GlobeNewswire EN)
|
|
|
CAMBRIDGE, Mass., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences, Inc. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, will host a live webcast and conference call at 8:30 a.m. ET on Tuesday, October 27, 2026, to review the company's third quarter 2026 financial results and provide business updates....
|
|
|
19.10.26 - 14:31
|
Wave Life Sciences to Host Virtual Research Day on Wednesday, November 4, 2026 (GlobeNewswire EN)
|
|
|
CAMBRIDGE, Mass., Oct. 19, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences, Inc. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, announced it will host a virtual Research Day on Wednesday, November 4, 2026 at 9:30 a.m. ET....
|
|
|
13.10.26 - 14:33
|
Wave Life Sciences to Present at Chardan′s 10th Annual Healthcare Conference (GlobeNewswire EN)
|
|
|
CAMBRIDGE, Mass., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences, Inc. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today announced that Paul Bolno, MD, MBA, President and Chief Executive Officer, is scheduled to participate in the “RNA Medicines: Next-Generation RNA Therapeutics” panel at Chardan's 10th Annual Healthcare Conference in New York City on Tuesday, October 20, 2026 at 9:45 a.m. ET....
|
|
|
|
|
09.10.26 - 22:33
|
CytoMed Therapeutics Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency (GlobeNewswire EN)
|
|
|
CytoMed Therapeutics Limited (the “Company”) (NASDAQ: GDTC), a Singapore-based clinical stage biopharmaceutical company focused on harnessing its proprietary technologies to develop novel affordable donor-derived, cell-based allogeneic immunotherapies, today announced that on October 6, 2026, the Company received a notice from the staff of the Nasdaq Listing Qualifications department of The Nasdaq Stock Market LLC (“Nasdaq”) stating that for the last 30 consecutive business days, the closing bid price of the Company's ordinary shares (the “Ordinary Shares”) was below the minimum bid price of US$1.00 per share requirement set forth in Nasdaq Listing Rule 5550(a)(2). The Nasdaq notification letter has no current effect on the listing or trading of the Company's Ordinary Shares on Nasdaq....
|
|
|
|
|
|
|
07.10.26 - 07:18
|
FV Hospital becomes Encare′s first partner hospital in Vietnam and aims for ERAS® Qualification (Cision)
|
|
|
Encare AB has signed an agreement with FV Hospital (Far East Medical Vietnam), its first partner hospital in Vietnam, to implement Enhanced Recovery After Surgery (ERAS[®]) across two surgical pathways: colorectal surgery and hip and knee arthroplasty. FV Hospital is a private hospital in Ho Chi Minh City and part of Thomson Medical Group, one of Southeast Asia's leading healthcare groups.
[Encare_FV_Hospital_Vietnam_ERAS.png]
FV Hospital in Ho Chi Minh City becomes Encare's first partner hospital in Vietnam.
STOCKHOLM, Sweden and HO CHI MINH CITY, Vietnam, 7 October 2026 – As part of...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
